EGFR signaling attenuates Groucho-dependent repression to antagonize Notch transcriptional outputHASSON, Peleg; EGOZ, Nirit; WINKLER, Clint et al.Nature genetics. 2005, Vol 37, Num 1, pp 101-105, issn 1061-4036, 5 p.Article

Emerging role of epidermal growth factor receptor inhibition in therapy for advanced malignancy: Focus on NSCLCLANGER, Corey J.International journal of radiation oncology, biology, physics. 2004, Vol 58, Num 3, pp 991-1002, issn 0360-3016, 12 p.Conference Paper

Blockade of epidermal growth factor receptor (EGFR) activityJIMENO, Antonio; HIDALGO, Manuel.Critical reviews in oncology/hematology. 2005, Vol 53, Num 3, pp 179-192, issn 1040-8428, 14 p.Article

The epidermal growth factor receptor signaling network in head and neck carcinogenesis and implications for targeted therapyPOMERANTZ, Rebecca G; GRANDIS, Jennifer Rubin.Seminars in oncology. 2004, Vol 31, Num 6, pp 734-743, issn 0093-7754, 10 p.Article

Small in-frame deletion in the epidermal growth factor receptor as a target for ZD6474ARAO, Tokuzo; FUKUMOTO, Hisao; TAKEDA, Masayuki et al.Cancer research (Baltimore). 2004, Vol 64, Num 24, pp 9101-9104, issn 0008-5472, 4 p.Article

Epidermal growth factor receptor in tumor angiogenesisELLIS, Lee M.Hematology/oncology clinics of North America. 2004, Vol 18, Num 5, issn 0889-8588, viii, 1007-1021 [14 p.]Article

Photochemical targeting of epidermal growth factor receptor: A mechanistic studySAVELLANO, Mark D; HASAN, Tayyaba.Clinical cancer research. 2005, Vol 11, Num 4, pp 1658-1668, issn 1078-0432, 11 p.Article

Upconversion nanoparticle-based ligase-assisted method for specific and sensitive detection of T790M mutation in epidermal growth factor receptorPENG WANG; JOSHI, Padmanabh; ALAZEMI, Abdulrahman et al.Biosensors & bioelectronics. 2014, Vol 62, pp 120-126, issn 0956-5663, 7 p.Article

Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancersSHIGEMATSU, Hisayuki; LI LIN; FUJISAWA, Takehiko et al.Journal of the National Cancer Institute. 2005, Vol 97, Num 5, pp 339-346, issn 0027-8874, 8 p.Article

Downregulation of TS, DPD, ERCC1, GST-Pi, EGFR, and HER2 Gene expression after neoadjuvant three-modality treatment in patients with esophageal cancerSCHNEIDER, Sylke; UCHIDA, Kazumi; HOELSCHER, Arnulf H et al.Journal of the American College of Surgeons. 2005, Vol 200, Num 3, pp 336-344, issn 1072-7515, 9 p.Article

Enhanced sensitivity to the HER1/epidermal growth factor receptor tyrosine kinase inhibitor erlotinib hydrochloride in chemotherapy-resistant tumor cell linesQUN DAI; LING, Yi-He; LIA, Marie et al.Clinical cancer research. 2005, Vol 11, Num 4, pp 1572-1578, issn 1078-0432, 7 p.Article

Epidermal growth factor receptor gene polymorphisms predict pelvic recurrence in patients with rectal cancer treated with chemoradiationWU ZHANG; PARK, David J; LENZ, Heinz-Josef et al.Clinical cancer research. 2005, Vol 11, Num 2, pp 600-605, issn 1078-0432, 6 p., 1Article

Magnetic resonance imaging in an orthotopic rat model: Blockade of epidermal growth factor receptor with EMD72000 inhibits human pancreatic carcinoma growthBANGARD, Christopher; GOSSMANN, Axel; PAPYAN, Armine et al.International journal of cancer. 2005, Vol 114, Num 1, pp 131-138, issn 0020-7136, 8 p.Article

Molecular mechanisms of resistance to therapies targeting the epidermal growth factor receptorCAMP, E. Ramsay; SUMMY, Justin; BAUER, Todd W et al.Clinical cancer research. 2005, Vol 11, Num 1, pp 397-405, issn 1078-0432, 9 p.Article

Phase ii study of gefitinib in patients with relapsed or persistent ovarian or primary peritoneal carcinoma and evaluation of epidermal growth factor receptor mutations and immunohistochemical expression : A gynecologic oncology group studySCHILDER, Russell J; SILL, Michael W; XIAOWEI CHEN et al.Clinical cancer research. 2005, Vol 11, Num 15, pp 5539-5548, issn 1078-0432, 10 p.Article

Protein overexpression and gene amplification of epidermal growth factor receptor in nonsmall cell lung carcinomas: An immunohistochemical and fluorescence in situ hybridization studySUZUKI, Shioto; DOBASHI, Yoh; SAKURAI, Hiroyuki et al.Cancer. 2005, Vol 103, Num 6, pp 1265-1273, issn 0008-543X, 9 p.Article

Small cell carcinoma of the bladder: a contemporary clinicopathological study of 51 casesABRAHAMS, N. A; MORAN, C; REYES, A. O et al.Histopathology. 2005, Vol 46, Num 1, pp 57-63, issn 0309-0167, 7 p.Article

Abrogation of head and neck squamous cell carcinoma growth by epidermal growth factor receptor ligand fused to Pseudomonas exotoxin transforming growth factor α-PE38THOMAS, Sufi M; QING ZENG; EPPERLY, Michael W et al.Clinical cancer research. 2004, Vol 10, Num 20, pp 7079-7087, issn 1078-0432, 9 p.Article

Expression and co-expression of the members of the epidermal growth factor receptor (EGFR) family in invasive breast carcinomaABD EL-REHIM, D. M; PINDER, S. E; PAISH, C. E et al.British journal of cancer. 2004, Vol 91, Num 8, pp 1532-1542, issn 0007-0920, 11 p.Article

Multicenter phase II study of erlotinib, an oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with recurrent or metastatic squamous cell cancer of the head and neckSOULIERES, Denis; SENZER, Neil N; VOKES, Everett E et al.Journal of clinical oncology. 2004, Vol 22, Num 1, pp 77-85, issn 0732-183X, 9 p.Article

Overexpression of the HER-2 oncogene does not play a role in high-grade osteosarcomasANNINGA, J. K; VAN DE VIJVER, M. J; CLETON-JANSEN, A. M et al.European journal of cancer (1990). 2004, Vol 40, Num 7, pp 963-970, issn 0959-8049, 8 p.Article

Small cell lung cancer cells express EGFR and tyrosine phosphorylation of EGFR is inhibited by gefitinib ('Iressa', ZD1839)TANNO, Sachie; OHSAKI, Yoshinobu; NAKANISHI, Kyoko et al.Oncology reports. 2004, Vol 12, Num 5, pp 1053-1057, issn 1021-335X, 5 p.Article

Src family kinases mediate epidermal growth factor receptor ligand cleavage, proliferation, and invasion of head and neck cancer cellsQING ZHANG; THOMAS, Sufi M; SICHUAN XI et al.Cancer research (Baltimore). 2004, Vol 64, Num 17, pp 6166-6173, issn 0008-5472, 8 p.Article

Deregulated cyclin D1 expression is associated with decreased efficacy of the selective epidermal growth factor receptor tyrosine kinase inhibitor gefitinib in head and neck squamous cell carcinoma cell linesKALISH, Larry H; KWONG, Rhonda A; COLE, Ian E et al.Clinical cancer research. 2004, Vol 10, Num 22, pp 7764-7774, issn 1078-0432, 11 p.Article

Epidermal growth factor receptor (EGFR) is overexpressed in anaplastic thyroid cancer, and the EGFR inhibitor gefitinib inhibits the growth of anaplastic thyroid cancerSCHIFF, Bradley A; MCMURPHY, Andrea B; HOLSINGER, F. Christopher et al.Clinical cancer research. 2004, Vol 10, Num 24, pp 8594-8602, issn 1078-0432, 9 p.Article